English
Home > Products > Perfluorotributylamine

China Perfluorotributylamine Factory

It is a good way to improve our products and service. Our mission is to develop creative products to customers with a good experience for Perfluorotributylamine,CAS NO 311-89-7,311-89-7, As a key enterprise of this industry, our corporation makes endeavours to become a leading supplier, dependant on the faith of expert quality & all over the world provider.
Perfluorotributylamine, Our solutions are widely recognized and trusted by users and can meet continuously changing of economic and social needs. We welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!

Related Products

Hot Products

  • Ebastine

    Ebastine

    Product Name:Ebastine
    Molecular Formula:C32H39NO2
    Molecular Weight;469.66
    CAS Registry Number;90729-43-4
  • 4-BROMO-2-TRIFLUOROMETHYLPYRIDINE

    4-BROMO-2-TRIFLUOROMETHYLPYRIDINE

    Product Name:4-BROMO-2-TRIFLUOROMETHYLPYRIDINE
    Molecular Formula:C6H3BrF3N
    Molecular Weight:225.99
    CAS Registry Number:887583-90-6
  • 1-Bromo-3,4-difluorobenzene

    1-Bromo-3,4-difluorobenzene

    Product Name:1-Bromo-3,4-difluorobenzene
    Molecular Formula:C6H3BrF2
    Molecular Weight:192.99
    CAS Registry Number:348-61-8
  • 3-Aminophenol

    3-Aminophenol

    Product Name:3-Aminophenol
    Molecular Formula:C6H7NO
    Molecular Weight:109.13
    CAS Registry Number:591-27-5
  • Disodium hydrogen phosphate dihydrate

    Disodium hydrogen phosphate dihydrate

    Product Name:Disodium hydrogen phosphate dihydrate
    Molecular Formula:2Na.HO4P.2H2O
    Molecular Weight:177.99
    CAS Registry Number:10028-24-7
  • Enasidenib mesylate

    Enasidenib mesylate

    Product Name:Enasidenib mesylate
    Molecular Formula:C20H21F6N7O4S
    Molecular Weight;569.4806592
    CAS Registry Number;1650550-25-6
  • Related Blog
  • Reviews

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept